STERIS STE Consumables — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by STERIS in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about STERIS's consumables — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is STERIS's consumables — revenue?
- STERIS (STE) reported consumables — revenue of $456.2M in Q1 2026.
- How has STERIS's consumables — revenue changed year-over-year?
- STERIS's consumables — revenue increased by 6.4% year-over-year, from $428.8M to $456.2M.
- What is the long-term trend for STERIS's consumables — revenue?
- Over 4 years (2022 to 2026), STERIS's consumables — revenue has grown at a 15.8% compound annual growth rate (CAGR), from $1B to $1.8B.
- What does consumables — revenue mean?
- This metric represents the total net sales generated from the sale of recurring, single-use products and supplies essential for sterilization, decontamination, and infection prevention processes. These revenues are driven by the ongoing utilization of medical equipment and facilities, reflecting the volume of procedures performed by healthcare providers and biopharma manufacturing activity. As a recurring revenue stream, it serves as a key indicator of the company's installed base utilization and long-term customer demand.